Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomiz... von Niemeyer–van der Kolk, Tessa, Buters, Thomas P., Krouwels, Lara, Boltjes, Jiry, de Kam, Marieke L., van der Wall, Hein, van Alewijk, Dirk C.J.G., van den Munckhof, Ellen H.A., Becker, Martin J., Feiss, Gary, Florencia, Edwin F., Prens, Errol P., Moerland, Matthijs, Burggraaf, Jacobus, Rissmann, Robert, van Doorn, Martijn B.A.

Volltext